SPL 2.04% 9.6¢ starpharma holdings limited

Targeted DEP™ shows sustained superior performance in ovarian cancer model, page-79

  1. 275 Posts.
    to answer ur q from before, the notable 2 are IMU (11mil) and PYC which both have great preclin data and are tiny. IMU even has human data. ill froth a lil when we get the full data from that trial or better get when it goes into phase 1.

    ps its great to see some proper discussion on this forum. not rubbish from fake posters or moookush and the constant ramblings of a poster clearly gone insane from the 5+yr wait
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.